Tempest Therapeutics Inc. Stock Forecast
Tempest Therapeutics Inc. stock downgraded to Sell Candidate
(Updated on Apr 25, 2024)
The Tempest Therapeutics Inc. stock price gained 1.16% on the last trading day (Thursday, 25th Apr 2024), rising from $3.44 to $3.48. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 5.14% from a day low at $3.31 to a day high of $3.48. The price has been going up and down for this period, and there has been a -9.61% loss for the last 2 weeks. Volume fell on the last day by -365 thousand shares and in total, 287 thousand shares were bought and sold for approximately $999.34 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $3.08 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -6.12% during the next 3 months and, with a 90% probability hold a price between $2.89 and $5.01 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
TPST Signals & Forecast
There are mixed signals in the stock today. The Tempest Therapeutics Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $3.72. On a fall, the stock will find some support from the short-term average at $3.30. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. A buy signal was issued from a pivot bottom point on Friday, April 19, 2024, and so far it has risen 12.26%. Further rise is indicated until a new top pivot has been found.
Support, Risk & Stop-loss for Tempest Therapeutics Inc. stock
Tempest Therapeutics Inc. finds support from accumulated volume at $3.43 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.170 between high and low, or 5.14%. For the last week the stock has had daily average volatility of 6.27%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (TPST) For The Upcoming Trading Day Of Friday 26th
For the upcoming trading day on Friday, 26th we expect Tempest Therapeutics Inc. to open at $3.42, and during the day (based on 14 day Average True Range), to move between $3.14 and $3.82, which gives a possible trading interval of +/-$0.337 (+/-9.68%) up or down from last closing price. If Tempest Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 19.35% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $3.43 (1.44%) than the resistance at $3.70 (6.32%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Tempest Therapeutics Inc. stock A Buy?
Tempest Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.
Current score: -2.042 Sell Candidate Downgraded
Predicted Opening Price for Tempest Therapeutics Inc. of Friday, April 26, 2024
| Fair opening price April 26, 2024 | Current price |
|---|---|
| $3.42 ( 1.63%) | $3.48 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for TPST
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 3.59 | 3.26 % | |
| R2 | 3.53 | 1.39 % | ||
| R1 | 3.49 | 0.238 % | ||
| Current price: | 3.48 | |||
| Support | S1 | 3.36 | -3.49 % | |
| S2 | 3.32 | -4.65 % | ||
| S3 | 3.25 | -6.51 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 3.87 | 11.21 % | |
| R2 | 3.72 | 6.90 % | ||
| R1 | 3.70 | 6.32 % | ||
| Current price | 3.48 | |||
| Support | S1 | 3.43 | -1.44% | |
| S2 | 3.39 | -2.59% | ||
| S3 | 3.16 | -9.20% |
FAQ
Click here for our free guide on how to buy Tempest Therapeutics Inc. Stock.
